These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24991905)

  • 1. Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding.
    Ngoma MS; Hunter JA; Harper JA; Church PT; Mumba S; Chandwe M; Côté HC; Albert AY; Smith ML; Selemani C; Sandstrom PA; Bandenduck L; Ndlovu U; Khan S; Roa L; Silverman MS
    AIDS; 2014 Jul; 28 Suppl 3():S323-30. PubMed ID: 24991905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants.
    Whitehead N; Potterton J; Coovadia A
    AIDS Care; 2014 Apr; 26(4):497-504. PubMed ID: 24125015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa.
    le Roux SM; Donald KA; Brittain K; Phillips TK; Zerbe A; Nguyen KK; Strandvik A; Kroon M; Abrams EJ; Myer L
    AIDS; 2018 Aug; 32(13):1781-1791. PubMed ID: 29794831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early growth of infants of HIV-infected and uninfected Zambian women.
    Makasa M; Kasonka L; Chisenga M; Sinkala M; Chintu C; Tomkins A; Filteau S
    Trop Med Int Health; 2007 May; 12(5):594-602. PubMed ID: 17445127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.
    Chaudhury S; Williams PL; Mayondi GK; Leidner J; Holding P; Tepper V; Nichols S; Magetse J; Sakoi M; Moabi K; Makhema J; Mdluli C; Jibril H; Seage GR; Kammerer B; Lockman S
    Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28912368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers.
    Desmonde S; Goetghebuer T; Thorne C; Leroy V
    Curr Opin HIV AIDS; 2016 Sep; 11(5):465-476. PubMed ID: 27716731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
    Alimenti A; Burdge DR; Ogilvie GS; Money DM; Forbes JC
    Pediatr Infect Dis J; 2003 Sep; 22(9):782-9. PubMed ID: 14506368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy.
    Lindsey JC; Malee KM; Brouwers P; Hughes MD;
    Pediatrics; 2007 Mar; 119(3):e681-93. PubMed ID: 17296781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study.
    le Roux SM; Donald KA; Kroon M; Phillips TK; Lesosky M; Esterhuyse L; Zerbe A; Brittain K; Abrams EJ; Myer L
    Pediatr Infect Dis J; 2019 Jan; 38(1):70-75. PubMed ID: 30234792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.
    Ajaykumar A; Soudeyns H; Kakkar F; Brophy J; Bitnun A; Alimenti A; Albert AYK; Money DM; Côté HCF; ;
    J Infect Dis; 2018 Feb; 217(5):710-720. PubMed ID: 29228317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
    Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
    AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
    Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
    AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.
    Hofer CB; Keiser O; Zwahlen M; Lustosa CS; Frota AC; de Oliveira RH; Abreu TF; Carvalho AW; Araujo LE; Egger M
    Pediatr Infect Dis J; 2016 Jan; 35(1):71-7. PubMed ID: 26741583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of HIV-exposed uninfected, compared with HIV-unexposed, Zambian children: a longitudinal analysis from infancy to school age.
    Rosala-Hallas A; Bartlett JW; Filteau S
    BMC Pediatr; 2017 Mar; 17(1):80. PubMed ID: 28302082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
    Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
    AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.
    Koyanagi A; Humphrey JH; Ntozini R; Nathoo K; Moulton LH; Iliff P; Mutasa K; Ruff A; Ward B;
    Pediatr Infect Dis J; 2011 Jan; 30(1):45-51. PubMed ID: 21173675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
    Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
    AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.